Hawkins v. United States

District Court, W.D. Washington·Decided October 28, 2024·No. 2:16-cv-00498·Unknown

Opinion

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF WASHINGTON AT SEATTLE SABELITA HAWKINS, CASE NO. C16-0498JLR Plaintiff, ORDER v. UNITED STATES OF AMERICA, et al., Defendants. I. INTRODUCTION Before the court is Plaintiff Sabelita Hawkins’s motion for reconsideration of the court’s October 9, 2024 order granting Defendant the United States of America’s (the “United States”) motion for a protective order and denying Ms. Hawkins’s request for an extension of time to respond to that motion. (MFR (Dkt. # 76); Sykes Decl. (Dkt. # 78); see also MPO (Dkt. # 72); 10/9/24 Order (Dkt. # 75).) The court DENIES Ms. Hawkins’s motion for reconsideration. II. BACKGROUND1 AND ANALYSIS A motion for reconsideration is an “extraordinary remedy . . . to be used

sparingly” and the movant bears a “heavy burden.” Kona Enters., Inc. v. Estate of Bishop, 229 F.3d 877, 890 (9th Cir. 2000). “The court will ordinarily deny such motions in the absence of a showing of manifest error in the prior ruling or a showing of new facts or legal authority which could not have been brought to its attention earlier with reasonable diligence.” Local Rules W.D. Wash. 7(h)(1). Ms. Hawkins argues that the following “new facts” support her request for

reconsideration: (1) Ms. Hawkins’s counsel was taking new medications “that were affecting her memory and ability to concentrate” when Ms. Hawkins filed her September 26, 2024 response to the motion for protective order; (2) Ms. Hawkins “did not interpret” the court’s February 6, 2023 order as setting February 13, 2023 “as the final deadline” for liability discovery; and (3) Ms. Hawkins “never received [responses to] the supplemental

interrogatories related to the new records” from the United States. (MFR at 4-5; see also MFR at 2 (“[Ms. Hawkins] bring[s] to the Court’s attention new facts that [she] could not have brought to the attention of the Court earlier”); 2/6/23 Order (Dkt. # 64) (granting the parties’ stipulated motion to extend the deadline for the United States to respond to Ms. Hawkins’s supplemental interrogatories and to complete damages discovery to February

5, 2024).) The court addresses each of Ms. Hawkins’s arguments below. 1 The court detailed the factual and procedural background of this case in its October 9, 2024 order and does not repeat that background here, except as necessary to the court’s analysis. (See 10/9/24 Order at 2-4.) A. The Medications. Ms. Hawkins asks the court to reconsider its denial of her extension request

because two new medications “were affecting her [counsel’s] memory and ability to concentrate.” (MFR at 2, 4-5.) She asserts that these side effects “explain why [her counsel] could not have responded substantively” to the United States’s motion for protective order between September 20, 2024 and September 26, 2024. (MFR at 4 (quoting 10/9/24 Order).) Ms. Hawkins’s counsel represents that she was “unaware” of these side effects at the time she prepared her September 26 response to the motion for

protective order and that counsel did not learn of these side effects until she attended a post-operative appointment with her physician on October 10, 2024—two weeks after she filed the response. (MFR at 4; see also Sykes Decl. ¶ 3, Ex. A.)2 Ms. Hawkins asserts that these facts provide “[g]ood cause” to extend her deadline to respond to the United States’s motion for protective order. (MFR at 4-5 (citing Fed. R.

Civ. P. 6(b)(1)(A).) Ms. Hawkins does not explain, however, how the side effects counsel learned about after-the-fact would have prevented counsel from filing a substantive response to the United States’s motion for protective order between September 20 and September 26, when she in fact filed a nonsubstantive response on

2 Ms. Hawkins cites Exhibit A of the Sykes Declaration—an October 10, 2024 letter from counsel’s physician—to support her assertion that her counsel first learned about the side effects of her new medications on October 10, 2024. (MFR at 4 n.15.) The court notes, however, that counsel’s medications are not mentioned at all in the October 10, 2024 letter—they are mentioned in the letter dated October 22, 2024. (See generally Sykes Decl., Ex. A; see Sykes Decl. ¶ 4, Ex. B.) September 26. (See generally MPO Resp. (Dkt. # 73).) The court does not find these “new facts” persuasive.

B. The Liability Discovery Deadline. The court’s October 9, 2024 order provides in part that “neither party shall serve any further discovery in this case related to liability[.]” (10/9/24 Order at 5.) Ms. Hawkins asks the court to reconsider this part of the order because she “did not interpret” the court’s February 6, 2023 order as setting February 13, 2023 as the final deadline for liability discovery. (See MFR at 5 (citing 2/3/23 Joint Stip. (Dkt. # 63).) Rather, Ms.

Hawkins understood that the parties had agreed to extend all discovery deadlines past February 13, 2023. (See id. (citing 2/3/23 Joint Stip).) An analysis of Ms. Hawkins’s claim requires an understanding of the procedural history of this case. After the Ninth Circuit Court of Appeals remanded this matter, the court set the discovery completion deadline on February 13, 2023. (6/24/22 Sched. Order

(Dkt. # 60).) On January 13, 2023, the parties submitted a joint status report regarding “recently discovered” additional treatment providers whom Ms. Hawkins had not previously disclosed. (1/13/23 JSR (Dkt. # 61).) The parties sought an extension of the trial date and pretrial deadlines so the United States could “collect and review the records of these additional treatment providers” and because the parties “need[ed] to update the

damage discovery following the receipt of these records.” (2/3/23 Joint Stip. at 2.) The court granted the parties’ stipulated motion; continued trial to June 3, 2024; and reset the discovery completion deadline to February 5, 2024. (See 2/6/23 Order (Dkt. # 64) at 5; 2/7/23 Sched. Order (Dkt. # 65).) A week before the February 5, 2024 discovery deadline, Ms. Hawkins requested a further continuance of the trial and related pretrial deadlines. (1/29/24 Mot. (Dkt. # 66) at

Free access — add to your briefcase to read the full text and ask questions with AI

Hawkins v. United States, (W.D. Wash. 2024).

Hawkins v. United States (Hawkins v. United States) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.